marketcaparena
Search

    EHC

    Encompass Health Corp

    Company overview

    Market capitalization
    $12.23B
    Employees
    29,599
    Latest publication
    2026-09-29
    About Encompass Health Corp

    Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20102010-12-31 · USDQ4 20092009-12-31 · USDQ1 20062006-03-31 · USDQ4 20032003-12-31 · USDQ2 20002000-06-30 · USDQ3 19991999-09-30 · USDQ2 19991999-06-30 · USD
    Total Revenue1,597,400,000USD520,700,000USD479,600,000USD441,600,000USD3,957,604,000USD1,036,322,000USD993,300,000USD1,047,632,000USD
    Cost Of Revenue991,500,000USD380,900,000USD-745,500,000USD89,200,000USD3,201,210,000USD700,462,000USD671,100,000USD649,413,000USD
    Gross Profit605,900,000USD520,700,000USD1,225,100,000USD352,400,000USD756,394,000USD335,860,000USD322,200,000USD398,219,000USD
    Selling General Administrative62,600,000USD327,000,000USD295,400,000USD70,074,000USD0USD35,706,000USD168,100,000USD50,600,000USD
    General And Administrative Expenses62,600,000USD———————
    Other Operating Expenses254,900,000USD—402,500,000USD—————
    Total Operating Expenses317,500,000USD426,600,000USD1,148,000,000USD336,600,000USD0USD149,933,000USD262,800,000USD146,443,000USD
    Operating Income288,400,000USD94,100,000USD77,100,000USD15,800,000USD556,199,000USD185,927,000USD59,400,000USD251,776,000USD
    Total Other Income Expense Net-26,800,000USD-44,100,000USD-41,500,000USD-434,900,000USD0USD-78,137,000USD-66,500,000USD-63,343,000USD
    Interest Expense32,800,000USD34,500,000USD30,800,000USD85,375,000USD268,443,000USD52,059,000USD——
    Labor And Related Expense820,300,000USD———————
    Income Before Tax261,600,000USD50,000,000USD35,600,000USD-419,100,000USD0USD107,790,000USD-7,100,000USD188,433,000USD
    Income Tax Expense53,600,000USD-737,000,000USD-2,400,000USD13,700,000USD0USD42,577,000USD-2,800,000USD74,433,000USD
    Equity Method Income Loss100,000USD———————
    Discontinued Operations-600,000USD0USD0USD0USD0USD0USD——
    Net Income207,400,000USD779,200,000USD38,600,000USD-435,100,000USD0USD65,213,000USD-4,300,000USD114,000,000USD
    Minority Interest53,500,000USD10,600,000USD8,300,000USD8,700,000USD99,456,000USD27,865,000USD——
    Net Income Applicable To Common Shares153,900,000USD771,500,000USD19,500,000USD0USD0USD65,213,000USD——
    Research Development—0USD0USD0USD0USD0USD——
    Unclassified Operating Expenses—99,600,000USD198,800,000USD61,816,000USD—114,227,000USD94,700,000USD95,843,000USD
    Net Income From Continuing Ops—0USD0USD0USD0USD0USD——
    Ebit—84,500,000USD66,400,000USD15,800,000USD0USD185,927,000USD248,807,000USD443,550,000USD
    Ebitda—104,600,000USD83,900,000USD46,400,000USD—276,213,000USD154,100,000USD347,657,000USD
    Depreciation And Amortization—20,100,000USD17,500,000USD30,600,000USD—90,286,000USD-94,707,000USD-95,893,000USD
    Reconciled Depreciation—20,100,000USD17,500,000USD——90,286,000USD-94,700,000USD-95,900,000USD
    Selling And Marketing Expenses——251,300,000USD204,710,000USD————
    Source0000785161-26-000186DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 19971997-12-31 · USDFY 19961996-12-31 · USDFY 19941994-12-31 · USDFY 19931993-12-31 · USDFY 19921992-12-31 · USDFY 19911991-12-31 · USDFY 19901990-12-31 · USDFY 19891989-12-31 · USD
    Total Revenue3,123,200,000USD2,648,200,000USD1,127,441,000USD482,300,000USD407,000,000USD225,500,000USD180,500,000USD114,200,000USD
    Cost Of Revenue1,952,200,000USD1,718,100,000USD—348,900,000USD313,800,000USD165,600,000USD135,800,000USD85,200,000USD
    Gross Profit1,171,000,000USD930,100,000USD1,127,441,000USD133,400,000USD93,200,000USD59,900,000USD44,700,000USD29,000,000USD
    Selling General Administrative82,757,000USD66,807,000USD——————
    Unclassified Operating Expenses1,088,243,000USD863,293,000USD—133,400,000USD93,200,000USD59,900,000USD44,700,000USD29,000,000USD
    Total Operating Expenses1,171,000,000USD930,100,000USD1,127,441,000USD133,400,000USD93,200,000USD59,900,000USD44,700,000USD29,000,000USD
    Operating Income751,600,000USD572,800,000USD254,414,000USD70,200,000USD56,700,000USD39,900,000USD28,500,000USD17,000,000USD
    Interest Expense0USD0USD0USD0USD0USD0USD0USD0USD
    Income Before Tax556,800,000USD345,300,000USD87,263,000USD10,800,000USD45,000,000USD33,900,000USD20,100,000USD12,500,000USD
    Income Tax Expense213,700,000USD148,500,000USD33,835,000USD4,100,000USD15,300,000USD11,500,000USD7,200,000USD4,400,000USD
    Net Income343,100,000USD196,800,000USD53,225,000USD6,700,000USD29,700,000USD22,400,000USD12,900,000USD8,100,000USD
    Ebit751,600,000USD572,800,000USD254,414,000USD143,200,000USD107,700,000USD69,300,000USD50,700,000USD31,200,000USD
    Ebitda1,001,610,000USD761,766,000USD330,002,000USD106,700,000USD82,200,000USD54,600,000USD39,600,000USD24,100,000USD
    Depreciation And Amortization250,010,000USD188,966,000USD75,588,000USD-36,500,000USD-25,500,000USD-14,700,000USD-11,100,000USD-7,100,000USD
    Total Other Income Expense Net-194,800,000USD-227,500,000USD-167,151,000USD-59,400,000USD-11,700,000USD-6,000,000USD-8,400,000USD-4,500,000USD
    Other Operating Expenses——1,127,441,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets7,457,500,000USD7,313,200,000USD7,089,700,000USD6,865,700,000USD6,785,700,000USD6,641,300,000USD6,534,700,000USD6,458,400,000USD
    Cash And Equivalents107,700,000USD—72,200,000USD48,700,000USD99,100,000USD95,800,000USD85,400,000USD147,800,000USD
    Total Current Assets1,041,000,000USD1,029,099,999USD905,900,000USD869,800,000USD918,100,000USD910,900,000USD886,900,000USD933,900,000USD
    Other Current Assets220,200,000USD152,599,999USD141,600,000USD210,300,000USD135,000,000USD191,700,000USD202,700,000USD118,000,000USD
    Other Non Current Assets246,300,000USD———————
    Total Liabilities3,996,400,000USD———————
    Total Current Liabilities873,400,000USD876,800,000USD836,400,000USD762,000,000USD865,100,000USD856,000,000USD841,000,000USD897,400,000USD
    Other Current Liabilities588,400,000USD———————
    Other Non Current Liabilities212,200,000USD———————
    Total Stockholder Equity2,597,700,000USD2,521,700,000USD2,438,200,000USD2,373,800,000USD2,280,100,000USD2,159,100,000USD2,067,000,000USD1,959,800,000USD
    Total Equity Including Noncontrolling Interest3,461,100,000USD———————
    Long Term Debt2,598,100,000USD2,530,900,000USD2,447,200,000USD2,393,900,000USD2,320,300,000USD2,333,200,000USD2,359,200,000USD2,344,500,000USD
    Property Plant Equipment Net4,539,900,000USD4,421,800,000USD4,314,200,000USD4,143,600,000USD4,035,800,000USD3,942,400,000USD3,846,800,000USD3,733,400,000USD
    Goodwill1,323,500,000USD———————
    Intangible Assets306,800,000USD300,300,000USD308,300,000USD291,900,000USD295,900,000USD294,500,000USD297,800,000USD296,200,000USD
    Accounts Payable221,600,000USD204,000,000USD178,200,000USD138,400,000USD174,500,000USD159,100,000USD171,000,000USD170,300,000USD
    Short Term Debt27,500,000USD69,800,000USD70,100,000USD64,900,000USD164,700,000USD165,400,000USD164,900,000USD259,500,000USD
    Total Liab—3,946,000,000USD3,813,900,000USD3,679,400,000USD3,697,500,000USD3,703,700,000USD3,685,500,000USD3,732,800,000USD
    Other Current Liab—603,000,000USD588,100,000USD558,700,000USD525,900,000USD531,500,000USD505,100,000USD467,600,000USD
    Common Stock—1,200,000USD1,200,000USD1,200,000USD1,200,000USD1,200,000USD1,200,000USD1,200,000USD
    Capital Stock—1,200,000USD1,200,000USD1,200,000USD1,200,000USD1,200,000USD1,200,000USD1,200,000USD
    Retained Earnings—1,464,700,000USD1,289,400,000USD1,162,700,000USD1,055,599,999USD930,800,000USD796,700,000USD693,200,000USD
    Good Will—1,317,600,000USD1,317,600,000USD1,303,000,000USD1,303,000,000USD1,284,000,000USD1,284,000,000USD1,284,000,000USD
    Cash—163,400,000USD102,900,000USD48,700,000USD137,400,000USD95,800,000USD85,400,000USD198,900,000USD
    Cash And Short Term Investments—200,500,000USD145,100,000USD48,700,000USD170,600,000USD95,800,000USD85,400,000USD239,500,000USD
    Net Debt—2,626,000,000USD2,611,000,000USD2,612,900,000USD2,548,300,000USD2,607,000,000USD2,628,400,000USD2,600,600,000USD
    Short Long Term Debt—42,900,000USD43,600,000USD39,000,000USD139,200,000USD138,700,000USD138,600,000USD233,000,000USD
    Short Long Term Debt Total—2,789,400,000USD2,713,900,000USD2,661,600,000USD2,685,700,000USD2,702,800,000USD2,713,800,000USD2,799,500,000USD
    Short Term Investments—37,100,000USD42,200,000USD34,100,000USD33,200,000USD44,600,000USD39,000,000USD40,600,000USD
    Net Receivables—676,000,000USD619,200,000USD610,800,000USD612,500,000USD623,400,000USD598,800,000USD576,400,000USD
    Property Plant Equipment Gross—4,421,800,000USD6,687,000,000USD4,143,600,000USD4,035,800,000USD3,942,400,000USD5,958,700,000USD3,733,400,000USD
    Accumulated Other Comprehensive Income—-200,000USD500,000USD500,000USD300,000USD———
    Common Stock Shares Outstanding—100,600,000shares102,000,000shares102,300,000shares102,200,000shares102,100,000shares102,300,000shares102,100,000shares
    Non Current Assets Total—6,284,100,000USD6,183,800,000USD5,995,900,000USD5,867,599,999USD5,730,400,000USD5,647,800,000USD5,524,500,000USD
    Non Current Liabilities Total—3,069,200,000USD2,977,500,000USD2,917,400,000USD2,832,400,000USD2,847,700,000USD2,844,500,000USD2,835,400,000USD
    Non Current Liabilities Other—214,500,000USD206,900,000USD213,200,000USD200,800,000USD196,300,000USD190,400,000USD198,300,000USD
    Non Currrent Assets Other—135,200,000USD114,600,000USD257,400,000USD137,999,999USD131,200,000USD96,700,000USD120,500,000USD
    Net Working Capital—152,300,000USD69,500,000USD107,800,000USD53,000,000USD54,900,000USD45,900,000USD36,500,000USD
    Unclassified Non Current Assets—109,200,000USD—-151,700,000USD—-131,200,000USD-96,700,000USD-120,500,000USD
    Unclassified Current Liabilities—-42,900,000USD-43,600,000USD-39,000,000USD-139,200,000USD-138,700,000USD-138,600,000USD-233,000,000USD
    Unclassified Non Current Liabilities—323,800,000USD323,400,000USD310,300,000USD311,300,000USD318,200,000USD294,900,000USD292,600,000USD
    Unclassified Equity—1,054,800,000USD1,145,900,000USD1,208,200,000USD1,221,800,001USD1,225,900,000USD1,267,900,000USD1,264,200,000USD
    Other Assets——140,100,000USD151,700,000USD138,000,000USD209,500,000USD219,200,000USD210,900,000USD
    Unclassified Current Assets———-34,100,000USD—-44,600,000USD-39,000,000USD—
    Source0000785161-26-000186DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets7,089,700,000USD6,534,700,000USD6,102,400,000USD5,636,500,000USD6,864,900,000USD6,445,900,000USD6,080,700,000USD5,227,400,000USD
    Intangible Assets308,300,000USD297,800,000USD278,200,000USD282,300,000USD158,400,000USD431,300,000USD476,300,000USD443,400,000USD
    Other Current Assets141,600,000USD202,700,000USD88,400,000USD158,600,000USD369,900,000USD161,600,000USD162,300,000USD125,200,000USD
    Total Liab3,813,900,000USD3,685,500,000USD3,805,200,000USD3,774,600,000USD4,465,700,001USD4,444,300,000USD4,148,000,000USD3,356,300,000USD
    Total Stockholder Equity2,438,200,000USD2,067,000,000USD1,647,500,000USD1,310,300,000USD1,911,299,999USD1,588,000,000USD1,352,200,000USD1,329,100,000USD
    Other Current Liab588,100,000USD505,100,000USD437,500,000USD392,200,000USD553,500,000USD519,200,000USD546,700,000USD546,700,000USD
    Common Stock1,200,000USD1,200,000USD1,200,000USD1,100,000USD1,100,000USD1,100,000USD1,100,000USD1,100,000USD
    Capital Stock1,200,000USD1,200,000USD1,200,000USD1,100,000USD1,100,000USD1,100,000USD1,100,000USD1,100,000USD
    Retained Earnings1,289,400,000USD796,700,000USD406,500,000USD115,700,000USD141,800,000USD-242,300,000USD-526,500,000USD-885,200,000USD
    Good Will1,317,600,000USD1,284,000,000USD1,281,300,000USD1,263,200,000USD1,237,000,000USD2,318,700,000USD2,305,200,000USD2,100,800,000USD
    Other Assets140,100,000USD219,200,000USD1USD222,100,000USD254,500,000USD542,000,000USD300,200,000USD321,700,000USD
    Cash102,900,000USD85,400,000USD104,200,000USD21,800,000USD49,400,000USD224,000,000USD94,800,000USD69,200,000USD
    Cash And Equivalents72,200,000USD85,400,000USD69,100,000USD21,800,000USD54,800,000USD224,000,000USD94,800,000USD69,200,000USD
    Cash And Short Term Investments145,100,000USD85,400,000USD141,800,000USD21,800,000USD49,400,000USD224,000,000USD94,800,000USD69,200,000USD
    Total Current Assets905,900,000USD886,900,000USD841,800,000USD717,200,000USD921,400,000USD948,600,000USD755,800,000USD662,100,000USD
    Total Current Liabilities836,400,000USD841,000,000USD656,400,000USD575,900,000USD748,800,000USD717,300,000USD721,000,000USD672,500,000USD
    Net Debt2,611,000,000USD2,628,400,000USD2,828,600,000USD2,970,500,000USD3,432,000,000USD3,319,300,000USD3,252,000,000USD2,445,200,000USD
    Short Term Debt70,100,000USD164,900,000USD48,900,000USD50,800,000USD61,300,000USD83,100,000USD79,700,000USD35,800,000USD
    Short Long Term Debt43,600,000USD138,600,000USD24,800,000USD25,200,000USD42,800,000USD38,300,000USD39,300,000USD35,800,000USD
    Short Long Term Debt Total2,713,900,000USD2,713,800,000USD2,932,800,000USD2,992,300,000USD3,481,400,000USD3,543,300,000USD3,346,800,000USD2,514,400,000USD
    Long Term Debt2,447,200,000USD2,359,200,000USD2,687,800,000USD2,741,800,000USD3,243,900,000USD3,250,600,000USD3,023,300,000USD2,478,600,000USD
    Short Term Investments42,200,000USD39,000,000USD37,600,000USD—————
    Net Receivables619,200,000USD598,800,000USD611,600,000USD536,800,000USD502,100,000USD563,000,000USD498,700,000USD467,700,000USD
    Accounts Payable178,200,000USD171,000,000USD170,000,000USD132,900,000USD134,000,000USD115,000,000USD94,600,000USD90,000,000USD
    Property Plant Equipment Net4,314,200,000USD3,846,800,000USD3,509,500,000USD3,151,700,000USD2,774,900,000USD2,452,300,000USD2,235,800,000USD1,634,800,000USD
    Property Plant Equipment Gross6,687,000,000USD5,958,700,000USD5,381,700,000USD3,151,700,000USD2,843,600,000USD2,452,300,000USD2,235,800,000USD1,634,800,000USD
    Accumulated Other Comprehensive Income500,000USD———0USD0USD0USD0USD
    Common Stock Shares Outstanding102,200,000shares102,200,000shares101,300,000shares100,400,000shares100,200,000shares99,800,000shares99,400,000shares99,800,000shares
    Non Current Assets Total6,183,800,000USD5,647,800,000USD5,260,599,999USD4,919,300,000USD5,943,500,000USD5,497,300,000USD5,324,900,000USD4,565,300,000USD
    Non Current Liabilities Total2,977,500,000USD2,844,500,000USD3,148,799,999USD3,198,700,000USD3,716,900,001USD3,727,000,000USD3,427,000,000USD2,683,800,000USD
    Non Current Liabilities Other206,900,000USD190,400,000USD177,900,000USD173,800,000USD173,200,000USD209,600,000USD117,200,000USD119,600,000USD
    Non Currrent Assets Other114,600,000USD96,700,000USD82,099,999USD69,700,000USD1,550,700,000USD289,500,000USD300,200,000USD216,800,000USD
    Net Working Capital69,500,000USD45,900,000USD185,400,000USD141,300,000USD172,600,000USD231,300,000USD34,800,000USD-10,400,000USD
    Unclassified Current Liabilities-43,600,000USD-138,600,000USD-67,400,000USD-108,200,000USD-353,100,000USD-339,200,000USD-282,200,000USD-248,600,000USD
    Unclassified Non Current Liabilities323,400,000USD294,900,000USD283,099,999USD—-46,799,999USD-51,800,000USD126,600,000USD-119,600,000USD
    Unclassified Equity1,145,900,000USD1,267,900,000USD1,238,600,000USD1,192,400,000USD2,288,499,999USD2,325,500,000USD2,368,800,000USD2,640,000,000USD
    Unclassified Current Assets—-39,000,000USD-72,700,000USD-31,600,000USD-65,100,000USD-65,400,000USD-57,400,000USD-59,000,000USD
    Unclassified Non Current Assets—-96,700,000USD109,499,999USD-69,700,000USD—-536,500,000USD-300,200,000USD-164,400,000USD
    Current Deferred Revenue——42,600,000USD83,000,000USD310,300,000USD300,900,000USD242,900,000USD212,800,000USD
    Inventory——72,700,000USD31,600,000USD65,100,000USD65,400,000USD57,400,000USD59,000,000USD
    Other Liab———257,200,000USD259,900,000USD266,800,000USD159,900,000USD205,200,000USD
    Net Tangible Assets———-235,200,000USD-934,100,000USD-699,100,000USD-1,189,700,000USD-1,005,800,000USD
    Deferred Long Term Liab————86,700,000USD51,800,000USD——
    Treasury Stock————-521,200,000USD-497,400,000USD-492,300,000USD-427,900,000USD
    Long Term Investments——————7,400,000USD12,200,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation177,700,000USD
    Stock Based Compensation25,300,000USD
    Deferred Income Tax5,400,000USD
    Other Non Cash Items-10,200,000USD
    Change To Account Receivables-63,400,000USD
    Change To Liabilities30,900,000USD
    Change In Working Capital-60,900,000USD
    Operating Cash Flow616,000,000USD
    Capital Expenditures-382,700,000USD
    Net Investments21,100,000USD
    Other Investing Activities8,100,000USD
    Unclassified Investing Cash Flow-32,200,000USD
    Investing Cash Flow-385,700,000USD
    Net Debt Issuance-12,900,000USD
    Net Common Stock Issuance-176,700,000USD
    Common Dividends Paid-39,200,000USD
    Other Financing Activities-97,000,000USD
    Unclassified Financing Cash Flow146,400,000USD
    Financing Cash Flow-179,400,000USD
    Change In Cash30,600,000USD
    End Cash Flow133,500,000USD
    Source0000785161-26-000186DeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income178,100,000USD146,100,000USD174,600,000USD184,900,000USD196,500,000USD163,800,000USD147,800,000USD114,500,000USD
    Depreciation87,300,000USD96,000,000USD82,400,000USD79,900,000USD79,200,000USD78,000,000USD78,400,000USD72,900,000USD
    Stock Based Compensation11,500,000USD18,400,000USD14,300,000USD14,300,000USD9,500,000USD12,500,000USD12,900,000USD13,600,000USD
    Other Non Cash Items73,000,000USD71,600,000USD-200,000USD-1,500,000USD2,100,000USD13,100,000USD-1,700,000USD30,500,000USD
    Change To Account Receivables-53,200,000USD3,600,000USD-3,100,000USD9,000,000USD-24,700,000USD-26,100,000USD28,200,000USD8,600,000USD
    Change In Working Capital-33,800,000USD13,900,000USD1,800,000USD-3,900,000USD-7,500,000USD2,800,000USD32,500,000USD-11,800,000USD
    Total Cash From Operating Activities313,100,000USD346,000,000USD270,800,000USD270,200,000USD288,600,000USD278,800,000USD267,800,000USD217,400,000USD
    Capital Expenditures-162,400,000USD-229,300,000USD-187,100,000USD-156,900,000USD-163,100,000USD-198,700,000USD-147,500,000USD-156,900,000USD
    Free Cash Flow150,700,000USD116,699,999USD83,700,000USD113,300,000USD125,500,000USD80,100,000USD120,300,000USD60,500,000USD
    Total Cashflows From Investing Activities-150,100,000USD-237,600,000USD-201,300,000USD-165,400,000USD-158,500,000USD-203,700,000USD-161,500,000USD-143,500,000USD
    Net Borrowings90,000,000USD41,900,000USD-28,600,000USD-22,300,000USD-20,000,000USD-87,400,000USD-141,500,000USD—
    Total Cash From Financing Activities-102,500,000USD-99,200,000USD-113,200,000USD-90,200,000USD-130,400,000USD-150,900,000USD-89,500,000USD-64,500,000USD
    Dividends Paid-20,300,000USD-19,000,000USD-17,000,000USD-17,100,000USD-18,000,000USD-17,000,000USD-15,000,000USD-14,900,000USD
    Sale Purchase Of Stock-71,600,000USD-76,400,000USD-24,900,000USD-24,700,000USD-32,100,000USD-7,500,000USD-6,800,000USD-16,800,000USD
    Change In Cash60,500,000USD9,200,000USD-43,700,000USD14,600,000USD-300,000USD-75,800,000USD16,800,000USD9,400,000USD
    Begin Period Cash Flow102,900,000USD93,700,000USD137,400,000USD122,800,000USD123,100,000USD198,900,000USD182,100,000USD172,700,000USD
    End Period Cash Flow163,400,000USD102,900,000USD93,700,000USD137,400,000USD122,800,000USD123,100,000USD198,900,000USD182,100,000USD
    Other Cashflows From Investing Activities-4,200,000USD-8,300,000USD-4,100,000USD-1,700,000USD-6,400,000USD12,900,000USD18,400,000USD-2,500,000USD
    Other Cashflows From Financing Activities-100,600,000USD-45,700,000USD-42,700,000USD-26,100,000USD-60,300,000USD-39,000,000USD73,800,000USD-20,700,000USD
    Unclassified Investing Cash Flow16,500,000USD—191,200,000USD158,600,000USD169,500,000USD185,800,000USD129,100,000USD174,300,000USD
    Investments——-201,300,000USD-165,400,000USD-158,500,000USD-203,700,000USD-161,500,000USD-158,400,000USD
    Unclassified Operating Cash Flow———-3,500,000USD8,800,000USD8,600,000USD—-2,300,000USD
    Unclassified Financing Cash Flow———————-12,100,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income567,200,000USD599,400,000USD361,600,000USD365,900,000USD517,600,000USD368,800,000USD446,400,000USD374,300,000USD
    Depreciation327,900,000USD299,600,000USD273,900,000USD243,600,000USD256,600,000USD243,000,000USD218,700,000USD199,700,000USD
    Stock Based Compensation56,500,000USD48,300,000USD50,600,000USD29,200,000USD32,800,000USD29,500,000USD114,400,000USD85,900,000USD
    Other Non Cash Items253,900,000USD22,900,000USD110,500,000USD69,600,000USD-1,000,000USD18,300,000USD-4,100,000USD65,600,000USD
    Change To Account Receivables-15,200,000USD3,000,000USD-22,400,000USD-16,900,000USD-64,300,000USD-38,100,000USD-22,900,000USD7,000,000USD
    Change In Working Capital4,300,000USD21,900,000USD50,300,000USD-30,400,000USD-118,000,000USD-7,300,000USD-180,100,000USD46,000,000USD
    Total Cash From Operating Activities1,175,600,000USD1,002,800,000USD850,800,000USD705,800,000USD715,800,000USD704,700,000USD635,300,000USD762,400,000USD
    Capital Expenditures-736,400,000USD-642,500,000USD-583,100,000USD-584,100,000USD-551,200,000USD-408,200,000USD-404,100,000USD-270,500,000USD
    Free Cash Flow439,200,000USD360,300,000USD267,700,000USD121,700,000USD164,600,000USD296,500,000USD231,200,000USD491,900,000USD
    Total Cashflows From Investing Activities-762,800,000USD-653,300,000USD-602,800,000USD-627,000,000USD-666,300,000USD-407,500,000USD-657,400,000USD-424,500,000USD
    Net Borrowings-29,000,000USD-242,000,000USD-83,300,000USD-498,200,000USD-66,300,000USD208,900,000USD454,500,000USD20,600,000USD
    Total Cash From Financing Activities-433,000,000USD-330,600,000USD-197,200,000USD-145,700,000USD-240,100,000USD-145,900,000USD48,200,000USD-321,200,000USD
    Dividends Paid-71,100,000USD-62,800,000USD-60,400,000USD-99,000,000USD-112,400,000USD-111,900,000USD-108,700,000USD-100,800,000USD
    Sale Purchase Of Stock-158,000,000USD-31,100,000USD-8,200,000USD-7,300,000USD-6,100,000USD-6,100,000USD-45,900,000USD-65,600,000USD
    Change In Cash-20,200,000USD18,900,000USD50,800,000USD-66,900,000USD-190,600,000USD151,300,000USD26,100,000USD16,700,000USD
    Begin Period Cash Flow123,100,000USD104,200,000USD53,400,000USD120,300,000USD310,900,000USD159,600,000USD133,500,000USD116,800,000USD
    End Period Cash Flow102,900,000USD123,100,000USD104,200,000USD53,400,000USD120,300,000USD310,900,000USD159,600,000USD133,500,000USD
    Other Cashflows From Investing Activities-14,800,000USD-7,200,000USD3,300,000USD-42,900,000USD3,500,000USD-11,500,000USD231,500,000USD-8,400,000USD
    Other Cashflows From Financing Activities-174,900,000USD5,300,000USD-45,300,000USD703,300,000USD203,600,000USD-234,600,000USD-273,200,000USD-116,900,000USD
    Unclassified Operating Cash Flow-34,200,000USD10,700,000USD—27,900,000USD27,800,000USD52,400,000USD40,000,000USD-9,100,000USD
    Unclassified Investing Cash Flow-11,600,000USD649,700,000USD578,100,000USD627,000,000USD547,700,000USD419,700,000USD172,600,000USD-210,700,000USD
    Investments—-653,300,000USD-601,100,000USD-627,000,000USD-666,300,000USD-407,500,000USD-657,400,000USD65,100,000USD
    Change To Liabilities———2,300,000USD14,900,000USD13,600,000USD-6,100,000USD6,600,000USD
    Unclassified Financing Cash Flow———-244,500,000USD-258,900,000USD-2,200,000USD21,500,000USD-58,500,000USD
    Cash And Cash Equivalents Changes————-190,600,000USD151,300,000USD26,100,000USD16,700,000USD
    Change To Inventory———————-2,400,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Average length of stay

    Period endPeriodValueUnitSource
    No published observations yet.

    Contract labor full-time equivalents

    Period endPeriodValueUnitSource
    No published observations yet.

    Discharges

    Period endPeriodValueUnitSource
    No published observations yet.

    Employees per occupied bed

    Period endPeriodValueUnitSource
    No published observations yet.

    Inpatient rehabilitation hospitals operated

    Period endPeriodValueUnitSource
    No published observations yet.

    Internal full-time equivalents

    Period endPeriodValueUnitSource
    No published observations yet.

    Licensed beds

    Period endPeriodValueUnitSource
    No published observations yet.

    Net patient revenue per discharge

    Period endPeriodValueUnitSource
    No published observations yet.

    Occupancy

    Period endPeriodValueUnitSource
    No published observations yet.

    Occupied beds

    Period endPeriodValueUnitSource
    No published observations yet.

    Outpatient visits

    Period endPeriodValueUnitSource
    No published observations yet.

    Same-store discharge growth

    Period endPeriodValueUnitSource
    No published observations yet.

    Total full-time equivalents

    Period endPeriodValueUnitSource
    No published observations yet.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2025Yearly · 2025-12-31ProductInpatient5,756,300,000USD0000785161-26-000081
    FY 2025Yearly · 2025-12-31ProductOther178,900,000USD0000785161-26-000081
    FY 2024Yearly · 2024-12-31ProductInpatient5,230,500,000USD0000785161-26-000081
    FY 2024Yearly · 2024-12-31ProductOther142,700,000USD0000785161-26-000081
    Q3 2024Quarterly · 2024-09-30ProductManaged Care148,100,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductMedicaid46,100,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductMedicare883,300,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductMedicare Advantage220,900,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductOther Income Source31,500,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductOther Thirdparty Payors10,000,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductPatients4,100,000USD0000785161-24-000050
    Q3 2024Quarterly · 2024-09-30ProductWorkers Compensation7,000,000USD0000785161-24-000050
    Q2 2024Quarterly · 2024-06-30ProductManaged Care138,700,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductMedicaid43,000,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductMedicare841,600,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductMedicare Advantage224,200,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductOther Income Source32,500,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductOther Thirdparty Payors10,700,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductPatients3,700,000USD0000785161-24-000043
    Q2 2024Quarterly · 2024-06-30ProductWorkers Compensation6,800,000USD0000785161-24-000043
    Q1 2024Quarterly · 2024-03-31ProductManaged Care142,800,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductMedicaid44,800,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductMedicare854,100,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductMedicare Advantage223,800,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductOther Income Source30,100,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductOther Thirdparty Payors9,500,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductPatients3,900,000USD0000785161-24-000028
    Q1 2024Quarterly · 2024-03-31ProductWorkers Compensation7,000,000USD0000785161-24-000028
    FY 2023Yearly · 2023-12-31ProductInpatient4,693,800,000USD0000785161-26-000081
    FY 2023Yearly · 2023-12-31ProductOther107,400,000USD0000785161-26-000081
    Q3 2023Quarterly · 2023-09-30ProductManaged Care135,400,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductMedicaid49,200,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductMedicare786,500,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductMedicare Advantage191,700,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductOther Income Source23,100,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductOther Thirdparty Payors10,600,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductPatients3,800,000USD0000785161-24-000050
    Q3 2023Quarterly · 2023-09-30ProductWorkers Compensation6,600,000USD0000785161-24-000050
    Q2 2023Quarterly · 2023-06-30ProductManaged Care133,500,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductMedicaid48,800,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductMedicare763,200,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductMedicare Advantage198,100,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductOther Income Source21,600,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductOther Thirdparty Payors10,600,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductPatients4,000,000USD0000785161-24-000043
    Q2 2023Quarterly · 2023-06-30ProductWorkers Compensation7,300,000USD0000785161-24-000043
    Q1 2023Quarterly · 2023-03-31ProductManaged Care127,100,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductMedicaid47,400,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductMedicare757,700,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductMedicare Advantage186,200,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductOther Income Source22,700,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductOther Thirdparty Payors10,900,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductPatients2,700,000USD0000785161-24-000028
    Q1 2023Quarterly · 2023-03-31ProductWorkers Compensation5,700,000USD0000785161-24-000028
    FY 2022Yearly · 2022-12-31ProductInpatient4,251,600,000USD0000785161-25-000009
    FY 2022Yearly · 2022-12-31ProductOutpatient And Other97,000,000USD0000785161-25-000009
    Q3 2022Quarterly · 2022-09-30ProductManaged Care126,100,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductMedicaid47,700,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductMedicare711,200,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductMedicare Advantage163,600,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductOther Income Source21,000,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductOther Thirdparty Payors9,500,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductPatients3,500,000USD0000785161-23-000070
    Q3 2022Quarterly · 2022-09-30ProductWorkers Compensation6,900,000USD0000785161-23-000070
    Q2 2022Quarterly · 2022-06-30ProductManaged Care123,300,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductMedicaid47,500,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductMedicare690,700,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductMedicare Advantage160,700,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductOther Income Source20,900,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductOther Thirdparty Payors9,400,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductPatients4,100,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30ProductWorkers Compensation5,900,000USD0000785161-23-000052
    Q2 2022Quarterly · 2022-06-30SegmentHome Healthand Hospice268,000,000USD0000785161-22-000038
    Q2 2022Quarterly · 2022-06-30SegmentInpatient Rehabilitation1,062,500,000USD0000785161-22-000038
    Q1 2022Quarterly · 2022-03-31SegmentHome Healthand Hospice274,300,000USD0000785161-22-000021
    Q1 2022Quarterly · 2022-03-31SegmentInpatient Rehabilitation1,059,300,000USD0000785161-22-000021
    Q4 2021Quarterly · 2021-12-31SegmentHome Healthand Hospice276,100,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31SegmentInpatient Rehabilitation1,042,600,000USDLegacy provider
    FY 2021Yearly · 2021-12-31SegmentHome Healthand Hospice1,106,600,000USD0000785161-22-000008
    FY 2021Yearly · 2021-12-31SegmentInpatient Rehabilitation4,015,000,000USD0000785161-22-000008
    Q3 2021Quarterly · 2021-09-30SegmentHome Healthand Hospice273,900,000USD0000785161-21-000050
    Q3 2021Quarterly · 2021-09-30SegmentInpatient Rehabilitation1,010,900,000USD0000785161-21-000050
    Q2 2021Quarterly · 2021-06-30SegmentHome Healthand Hospice286,100,000USD0000785161-22-000038
    Q2 2021Quarterly · 2021-06-30SegmentInpatient Rehabilitation1,001,600,000USD0000785161-22-000038
    Q1 2021Quarterly · 2021-03-31SegmentHome Healthand Hospice270,500,000USD0000785161-22-000021
    Q1 2021Quarterly · 2021-03-31SegmentInpatient Rehabilitation959,900,000USD0000785161-22-000021
    Q4 2020Quarterly · 2020-12-31SegmentHome Healthand Hospice281,300,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31SegmentInpatient Rehabilitation933,100,000USDLegacy provider
    FY 2020Yearly · 2020-12-31SegmentHome Healthand Hospice1,078,200,000USD0000785161-22-000008
    FY 2020Yearly · 2020-12-31SegmentInpatient Rehabilitation3,566,200,000USD0000785161-22-000008
    Q3 2020Quarterly · 2020-09-30SegmentHome Healthand Hospice274,500,000USD0000785161-21-000050
    Q3 2020Quarterly · 2020-09-30SegmentInpatient Rehabilitation899,400,000USD0000785161-21-000050
    FY 2019Yearly · 2019-12-31SegmentHome Healthand Hospice1,092,000,000USD0000785161-22-000008
    FY 2019Yearly · 2019-12-31SegmentInpatient Rehabilitation3,513,000,000USD0000785161-22-000008
    FY 2018Yearly · 2018-12-31SegmentHome Healthand Hospice931,100,000USD0000785161-21-000006
    FY 2018Yearly · 2018-12-31SegmentInpatient Rehabilitation3,346,200,000USD0000785161-21-000006
    FY 2017Yearly · 2017-12-31SegmentHome Healthand Hospice772,600,000USD0000785161-20-000011
    FY 2017Yearly · 2017-12-31SegmentInpatient Rehabilitation3,141,300,000USD0000785161-20-000011
    FY 2016Yearly · 2016-12-31SegmentHome Healthand Hospice678,500,000USD0000785161-19-000011
    FY 2016Yearly · 2016-12-31SegmentInpatient Rehabilitation2,964,100,000USD0000785161-19-000011

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.